Literature DB >> 21754478

(5-Bromo-2-meth-oxy-phen-yl)(4-ethyl-cyclo-hex-yl)methanone.

Ling Wang, Ziqian Chang, Chunlei Ding, Hua Shao, Jianzi Sun.   

Abstract

In the title compound, C(16)H(21)BrO(2), the cyclo-hexane ring is in a chair conformation and its least-squares plane is at an angle of 61.3 (9)° to the benzene ring. The crystal packing is stabilized by weak π-π stacking inter-actions [centroid-centroid distance = 3.697 (9) Å] between the bromo-meth-oxy-phenyl rings of neighbouring mol-ecules.

Entities:  

Year:  2011        PMID: 21754478      PMCID: PMC3089268          DOI: 10.1107/S1600536811013687

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the anti­hyperglycemic activity of SGLT2 inhibitors, see: Gao et al. (2010 ▶); Meng et al. (2008 ▶); Shao et al. (2010 ▶). For bond-length data, see: Allen et al. (1987 ▶).

Experimental

Crystal data

C16H21BrO2 M = 325.24 Monoclinic, a = 14.204 (3) Å b = 11.276 (2) Å c = 9.604 (2) Å β = 102.329 (4)° V = 1502.8 (6) Å3 Z = 4 Mo Kα radiation μ = 2.73 mm−1 T = 113 K 0.26 × 0.22 × 0.20 mm

Data collection

Rigaku Saturn CCD area-detector diffractometer Absorption correction: multi-scan (CrystalClear; Rigaku, 2007 ▶) T min = 0.537, T max = 0.611 13836 measured reflections 3588 independent reflections 2581 reflections with I > 2σ(I) R int = 0.033

Refinement

R[F 2 > 2σ(F 2)] = 0.024 wR(F 2) = 0.058 S = 1.04 3588 reflections 174 parameters H-atom parameters constrained Δρmax = 0.52 e Å−3 Δρmin = −0.28 e Å−3 Data collection: CrystalClear (Rigaku, 2007 ▶); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536811013687/bx2347sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536811013687/bx2347Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C16H21BrO2F(000) = 672
Mr = 325.24Dx = 1.438 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 5413 reflections
a = 14.204 (3) Åθ = 2.2–27.9°
b = 11.276 (2) ŵ = 2.73 mm1
c = 9.604 (2) ÅT = 113 K
β = 102.329 (4)°Prism, colorless
V = 1502.8 (6) Å30.26 × 0.22 × 0.20 mm
Z = 4
Rigaku Saturn CCD area-detector diffractometer3588 independent reflections
Radiation source: rotating anode2581 reflections with I > 2σ(I)
multilayerRint = 0.033
Detector resolution: 14.63 pixels mm-1θmax = 27.9°, θmin = 2.3°
ω and φ scansh = −18→18
Absorption correction: multi-scan (CrystalClear; Rigaku, 2007)k = −14→11
Tmin = 0.537, Tmax = 0.611l = −12→12
13836 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.024Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.058H-atom parameters constrained
S = 1.04w = 1/[σ2(Fo2) + (0.026P)2] where P = (Fo2 + 2Fc2)/3
3588 reflections(Δ/σ)max = 0.001
174 parametersΔρmax = 0.52 e Å3
0 restraintsΔρmin = −0.28 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Br10.359389 (12)1.039199 (15)0.078211 (19)0.02887 (7)
O10.67370 (8)1.14977 (9)0.58965 (11)0.0236 (3)
O20.71492 (8)0.90082 (11)0.30034 (13)0.0339 (3)
C10.66083 (12)1.24071 (14)0.68801 (17)0.0272 (4)
H1A0.65061.31700.63820.041*
H1B0.71841.24550.76500.041*
H1C0.60471.22190.72810.041*
C20.59954 (11)1.12527 (13)0.47931 (16)0.0176 (3)
C30.51379 (11)1.19027 (13)0.45009 (17)0.0202 (4)
H30.50461.25260.51240.024*
C40.44236 (11)1.16512 (13)0.33205 (17)0.0212 (4)
H40.38451.21020.31230.025*
C50.45613 (11)1.07334 (14)0.24293 (17)0.0193 (4)
C60.54008 (11)1.00793 (14)0.26967 (17)0.0181 (3)
H60.54820.94590.20630.022*
C70.61305 (11)1.03146 (12)0.38797 (16)0.0160 (3)
C80.70157 (11)0.95429 (13)0.40477 (17)0.0192 (3)
C90.77081 (11)0.93956 (12)0.54697 (17)0.0170 (3)
H90.73770.96410.62440.020*
C100.80398 (11)0.81086 (13)0.57217 (17)0.0205 (4)
H10A0.74740.75890.56900.025*
H10B0.83670.78530.49600.025*
C110.87275 (11)0.79932 (13)0.71633 (17)0.0208 (4)
H11A0.89300.71550.73170.025*
H11B0.83860.82170.79210.025*
C120.96177 (11)0.87687 (13)0.72848 (17)0.0205 (4)
H120.99710.85020.65450.025*
C130.93087 (11)1.00610 (14)0.69645 (18)0.0232 (4)
H13A0.90051.03620.77310.028*
H13B0.98871.05500.69590.028*
C140.86004 (10)1.01921 (14)0.55324 (17)0.0205 (4)
H14A0.89240.99710.47530.025*
H14B0.83941.10300.53930.025*
C151.02894 (11)0.86209 (15)0.87409 (18)0.0268 (4)
H15A0.99580.89270.94760.032*
H15B1.04050.77630.89230.032*
C161.12570 (12)0.92389 (19)0.8919 (2)0.0430 (5)
H16A1.15750.89880.81570.064*
H16B1.16620.90290.98460.064*
H16C1.11591.00990.88700.064*
U11U22U33U12U13U23
Br10.02108 (10)0.03198 (11)0.02822 (11)0.00216 (7)−0.00667 (7)0.00102 (8)
O10.0236 (6)0.0242 (6)0.0208 (6)0.0053 (5)−0.0002 (5)−0.0083 (5)
O20.0284 (7)0.0513 (8)0.0192 (7)0.0171 (6)−0.0011 (6)−0.0109 (6)
C10.0309 (10)0.0257 (9)0.0242 (9)0.0016 (8)0.0045 (8)−0.0107 (8)
C20.0187 (8)0.0196 (8)0.0147 (8)−0.0011 (6)0.0039 (7)0.0027 (7)
C30.0238 (9)0.0182 (8)0.0206 (9)0.0022 (7)0.0094 (7)0.0016 (7)
C40.0177 (8)0.0209 (9)0.0265 (9)0.0031 (6)0.0081 (7)0.0066 (7)
C50.0168 (8)0.0215 (8)0.0178 (8)−0.0019 (6)−0.0002 (7)0.0053 (7)
C60.0209 (9)0.0173 (8)0.0162 (8)−0.0005 (6)0.0040 (7)0.0027 (6)
C70.0159 (7)0.0164 (8)0.0162 (8)−0.0005 (6)0.0044 (6)0.0034 (7)
C80.0164 (8)0.0219 (8)0.0188 (8)0.0005 (6)0.0028 (7)−0.0019 (7)
C90.0151 (8)0.0199 (8)0.0157 (8)−0.0003 (6)0.0027 (6)−0.0017 (7)
C100.0175 (8)0.0192 (8)0.0240 (9)−0.0001 (6)0.0029 (7)−0.0020 (7)
C110.0215 (8)0.0162 (8)0.0235 (9)0.0013 (6)0.0024 (7)0.0014 (7)
C120.0169 (8)0.0229 (9)0.0202 (9)0.0017 (6)0.0007 (7)−0.0016 (7)
C130.0180 (9)0.0205 (8)0.0283 (10)−0.0041 (7)−0.0011 (8)0.0038 (7)
C140.0178 (8)0.0208 (9)0.0225 (9)−0.0016 (6)0.0036 (7)0.0036 (7)
C150.0244 (9)0.0262 (9)0.0259 (10)0.0017 (7)−0.0035 (8)0.0000 (8)
C160.0230 (10)0.0583 (13)0.0406 (13)−0.0021 (9)−0.0089 (9)0.0032 (10)
Br1—C51.9002 (16)C10—C111.520 (2)
O1—C21.3536 (17)C10—H10A0.9900
O1—C11.4322 (17)C10—H10B0.9900
O2—C81.2192 (18)C11—C121.521 (2)
C1—H1A0.9800C11—H11A0.9900
C1—H1B0.9800C11—H11B0.9900
C1—H1C0.9800C12—C151.524 (2)
C2—C31.398 (2)C12—C131.534 (2)
C2—C71.413 (2)C12—H121.0000
C3—C41.380 (2)C13—C141.528 (2)
C3—H30.9500C13—H13A0.9900
C4—C51.383 (2)C13—H13B0.9900
C4—H40.9500C14—H14A0.9900
C5—C61.379 (2)C14—H14B0.9900
C6—C71.390 (2)C15—C161.518 (2)
C6—H60.9500C15—H15A0.9900
C7—C81.509 (2)C15—H15B0.9900
C8—C91.512 (2)C16—H16A0.9800
C9—C101.529 (2)C16—H16B0.9800
C9—C141.544 (2)C16—H16C0.9800
C9—H91.0000
C2—O1—C1118.36 (12)C9—C10—H10B109.7
O1—C1—H1A109.5H10A—C10—H10B108.2
O1—C1—H1B109.5C10—C11—C12112.50 (13)
H1A—C1—H1B109.5C10—C11—H11A109.1
O1—C1—H1C109.5C12—C11—H11A109.1
H1A—C1—H1C109.5C10—C11—H11B109.1
H1B—C1—H1C109.5C12—C11—H11B109.1
O1—C2—C3123.32 (14)H11A—C11—H11B107.8
O1—C2—C7116.91 (14)C11—C12—C15110.78 (13)
C3—C2—C7119.73 (15)C11—C12—C13109.46 (12)
C4—C3—C2120.91 (15)C15—C12—C13112.58 (13)
C4—C3—H3119.5C11—C12—H12108.0
C2—C3—H3119.5C15—C12—H12108.0
C3—C4—C5119.06 (15)C13—C12—H12108.0
C3—C4—H4120.5C14—C13—C12112.18 (13)
C5—C4—H4120.5C14—C13—H13A109.2
C6—C5—C4121.06 (15)C12—C13—H13A109.2
C6—C5—Br1119.32 (12)C14—C13—H13B109.2
C4—C5—Br1119.61 (12)C12—C13—H13B109.2
C5—C6—C7120.96 (15)H13A—C13—H13B107.9
C5—C6—H6119.5C13—C14—C9110.86 (13)
C7—C6—H6119.5C13—C14—H14A109.5
C6—C7—C2118.28 (14)C9—C14—H14A109.5
C6—C7—C8115.86 (14)C13—C14—H14B109.5
C2—C7—C8125.85 (14)C9—C14—H14B109.5
O2—C8—C7118.01 (14)H14A—C14—H14B108.1
O2—C8—C9120.22 (14)C16—C15—C12115.32 (15)
C7—C8—C9121.75 (14)C16—C15—H15A108.4
C8—C9—C10111.48 (13)C12—C15—H15A108.4
C8—C9—C14109.97 (13)C16—C15—H15B108.4
C10—C9—C14108.86 (13)C12—C15—H15B108.4
C8—C9—H9108.8H15A—C15—H15B107.5
C10—C9—H9108.8C15—C16—H16A109.5
C14—C9—H9108.8C15—C16—H16B109.5
C11—C10—C9109.99 (12)H16A—C16—H16B109.5
C11—C10—H10A109.7C15—C16—H16C109.5
C9—C10—H10A109.7H16A—C16—H16C109.5
C11—C10—H10B109.7H16B—C16—H16C109.5
C1—O1—C2—C35.2 (2)C2—C7—C8—C922.2 (2)
C1—O1—C2—C7−177.20 (13)O2—C8—C9—C10−39.5 (2)
O1—C2—C3—C4176.77 (14)C7—C8—C9—C10138.54 (14)
C7—C2—C3—C4−0.8 (2)O2—C8—C9—C1481.31 (18)
C2—C3—C4—C50.7 (2)C7—C8—C9—C14−100.62 (16)
C3—C4—C5—C6−0.6 (2)C8—C9—C10—C11−179.57 (13)
C3—C4—C5—Br1−178.97 (11)C14—C9—C10—C1158.95 (17)
C4—C5—C6—C70.7 (2)C9—C10—C11—C12−59.46 (17)
Br1—C5—C6—C7179.06 (11)C10—C11—C12—C15−179.67 (13)
C5—C6—C7—C2−0.8 (2)C10—C11—C12—C1355.60 (18)
C5—C6—C7—C8−179.56 (14)C11—C12—C13—C14−53.76 (18)
O1—C2—C7—C6−176.87 (13)C15—C12—C13—C14−177.44 (14)
C3—C2—C7—C60.9 (2)C12—C13—C14—C956.16 (18)
O1—C2—C7—C81.7 (2)C8—C9—C14—C13179.77 (13)
C3—C2—C7—C8179.47 (14)C10—C9—C14—C13−57.84 (17)
C6—C7—C8—O218.9 (2)C11—C12—C15—C16172.94 (15)
C2—C7—C8—O2−159.73 (16)C13—C12—C15—C16−64.1 (2)
C6—C7—C8—C9−159.20 (14)
  2 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.

Authors:  Wei Meng; Bruce A Ellsworth; Alexandra A Nirschl; Peggy J McCann; Manorama Patel; Ravindar N Girotra; Gang Wu; Philip M Sher; Eamonn P Morrison; Scott A Biller; Robert Zahler; Prashant P Deshpande; Annie Pullockaran; Deborah L Hagan; Nathan Morgan; Joseph R Taylor; Mary T Obermeier; William G Humphreys; Ashish Khanna; Lorell Discenza; James G Robertson; Aiying Wang; Songping Han; John R Wetterau; Evan B Janovitz; Oliver P Flint; Jean M Whaley; William N Washburn
Journal:  J Med Chem       Date:  2008-02-09       Impact factor: 7.446

  2 in total
  4 in total

1.  (5-Bromo-2-hy-droxy-phen-yl)(4-propyl-cyclo-hex-yl)methanone.

Authors:  Kang Meng; Miao Cao; Zhuo-Ling An; Jie Zhang; Li-Hong Liu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-24

2.  (4-Meth-oxy-phen-yl)(4-propyl-cyclo-hex-yl)methanone.

Authors:  Ling Wang; Zi-Qian Chang; Jie Zhang; Cheng-Min Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-02-20

3.  (4-Ethyl-cyclo-hex-yl)(4-meth-oxy-phen-yl)methanone.

Authors:  Chun-Lei Ding; Yong-Jie Wu; Yi Zhang; Li Zhou
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-02-06

4.  (4-Meth-oxy-phen-yl)(4-methyl-cyclo-hex-yl)methanone.

Authors:  Wei Liu; Lida Tang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.